MRK
Merck & Co., Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$146.76
−0.27%Forward multiples
Based on analyst estimates
- P/E forward
- 17.01x
- P/E 2026E
- 53.16x
- P/E 2027E
- 15.29x
- P/E 2028E
- 13.84x
- P/S forward
- 5.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- 116.48x
- PEG TTM
- 0.20x
- Price / book
- 8.63x
- Price / sales
- 5.45x
- Price / cash flow
- 18.13x
Enterprise value
- Enterprise value
- $408.9B
- EV / sales
- 6.16x
- EV / EBITDA
- 29.54x
- EV / EBIT
- 36.98x
- Market cap
- $362.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026